Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.
Saved in:
| Title: | Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible. |
|---|---|
| Authors: | Fogarty, Gerald B.1,2,3 Gerald.fogarty@cancer.com.au, Angela Hong1,2,3 ahong@email.cs.nsw.gov.au, Jacobsen, Kari Dolven4 Kari.Dolven.Jacobsen@radiumhospitalet.no, Reisse, Claudius H.4 clarei@ous-hf.no, Shivalingam, Brindha1,2 brindha@brain-surgeon.com.au, Burmeister, Bryan3,5 Bryan_Burmeister@health.qld.gov.au, Haydu, Lauren E.1,6 lhaydu@uni.sydney.edu.au, Paton, Elizabeth6 elizabeth.paton@melanoma.org.au, Thompson, John F.1,2 john.thompson@melanoma.org.au |
| Source: | BMC Research Notes. 2014, Vol. 7 Issue 1, p2-16. 15p. 6 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 17560500 |
|---|---|
| DOI: | 10.1186/1756-0500-7-412 |
